Cao Y, Miao XP, Huang MY, Deng L, Lin DX, Zeng YX, Shao JY. Polymorphisms ofdeath pathway genes FAS and FASL and risk of nasopharyngeal carcinoma. MolCarcinog. 2010 Nov;49(11):944-50. doi: 10.1002/mc.20676.
Dowdell KC, Niemela JE, Price S, Davis J, Hornung RL, Oliveira JB, Puck JM,Jaffe ES, Pittaluga S, Cohen JI, Fleisher TA, Rao VK. Somatic FAS mutations arecommon in patients with genetically undefined autoimmune lymphoproliferativesyndrome. Blood. 2010 Jun 24;115(25):5164-9. doi: 10.1182/blood-2010-01-263145.
Fleisher TA, Straus SE, Bleesing JJ. A genetic disorder of lymphocyteapoptosis involving the fas pathway: the autoimmune lymphoproliferative syndrome.Curr Allergy Asthma Rep. 2001 Nov;1(6):534-40. Review.
Fleisher TA. The autoimmune lymphoproliferative syndrome: an experiment ofnature involving lymphocyte apoptosis. Immunol Res. 2008;40(1):87-92. doi:10.1007/s12026-007-8001-1.
Poppema S, Maggio E, van den Berg A. Development of lymphoma in AutoimmuneLymphoproliferative Syndrome (ALPS) and its relationship to Fas gene mutations.Leuk Lymphoma. 2004 Mar;45(3):423-31. Review.
Randhawa SR, Chahine BG, Lowery-Nordberg M, Cotelingam JD, Casillas AM.Underexpression and overexpression of Fas and Fas ligand: a double-edged sword.Ann Allergy Asthma Immunol. 2010 Apr;104(4):286-92. doi:10.1016/j.anai.2010.01.021. Review.
Rieux-Laucat F. Inherited and acquired death receptor defects in humanAutoimmune Lymphoproliferative Syndrome. Curr Dir Autoimmun. 2006;9:18-36.Review.
Sun T, Miao X, Zhang X, Tan W, Xiong P, Lin D. Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma. J Natl Cancer Inst.2004 Jul 7;96(13):1030-6.
Teachey DT, Seif AE, Grupp SA. Advances in the management and understanding ofautoimmune lymphoproliferative syndrome (ALPS). Br J Haematol. 2010Jan;148(2):205-16. doi: 10.1111/j.1365-2141.2009.07991.x.Review.
Turbyville JC, Rao VK. The autoimmune lymphoproliferative syndrome: A raredisorder providing clues about normal tolerance. Autoimmun Rev. 2010May;9(7):488-93. doi: 10.1016/j.autrev.2010.02.007.
Worth A, Thrasher AJ, Gaspar HB. Autoimmune lymphoproliferative syndrome:molecular basis of disease and clinical phenotype. Br J Haematol. 2006Apr;133(2):124-40. Review.
Zhang B, Sun T, Xue L, Han X, Zhang B, Lu N, Shi Y, Tan W, Zhou Y, Zhao D,Zhang X, Guo Y, Lin D. Functional polymorphisms in FAS and FASL contribute toincreased apoptosis of tumor infiltration lymphocytes and risk of breast cancer. Carcinogenesis. 2007 May;28(5):1067-73.
Zhang X, Miao X, Sun T, Tan W, Qu S, Xiong P, Zhou Y, Lin D. Functionalpolymorphisms in cell death pathway genes FAS and FASL contribute to risk of lungcancer. J Med Genet. 2005 Jun;42(6):479-84.
Contributor
MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register
: Vivi Li
You are not a member of the advisory board for this topic. If you want to update advisory board member profile, please contact office@encyclopedia.pub.
OK
Confirm
Only members of the Encyclopedia advisory board for this topic are allowed to note entries. Would you like to become an advisory board member of the Encyclopedia?